Funding for this research was provided by:
National Institute of General Medical Sciences (R01GM104303)
Boston Children's Hospital (PrecisionLink)
Children's Hospital of Philadelphia (Genomics Research and Innovation Network)
Cincinnati Children's Hospital Medical Center (Genomics Research and Innovation Network)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD075802)
National Center for Advancing Translational Sciences (U01TR002623)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
Received: 27 April 2019
Accepted: 20 August 2019
First Online: 4 September 2019
Change Date: 27 November 2019
Change Type: Update
Change Details: During the review process the authors added more detail regarding the output of the pilot projects. As such the authors should have updated the authorship with regard to the contributors to the two Pilot Projects discussed in detail (Epilepsy and Short Stature). These authors are Dr. Eric Marsh, Dr. Adda Grimberg and Dr. Colin Hawkes and are now added to this paper, and declare no conflicts of interest.
: T.G. is on the Scientific Advisory Board of Myriad Neuroscience and Clarigent Health. He has been an advisor/consultant to Supernus, Neurelis, ucb Pharma, Eisai, Sunovion, and SK Life Science. He receives royalties from Myriad Neuroscience and McGraw Hill Education. J.N.H. declares that he is on the Scientific Advisory Board of Camp4 Therapeutics. S.W.K. receives sponsored research support from Pfizer and Quest Diagnostics. K.D.M. receives sponsored research support from Quest Diagnostics. K.M. has received compensation as a consultant for Novartis. The other authors declare no conflicts of interest.